SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-012973
Filing Date
2019-01-18
Accepted
2019-01-18 16:50:35
Documents
4
Period of Report
2019-01-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d669818d8k.htm 8-K 19841
2 EX-5.1 d669818dex51.htm EX-5.1 8990
3 EX-10.1 d669818dex101.htm EX-10.1 198677
4 GRAPHIC g669818capture.jpg GRAPHIC 10072
  Complete submission text file 0001193125-19-012973.txt   237453
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 19533658
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10